Sparsentan as First-Line Treatment in IgAN From SPARTAN.

Cheung CK, Barratt WA, Chaki S, Chinnakotla S, Dhaun N, Graham-Brown MPM, Griffin S, Hendry B, Howson A, Jama AAA, Ju W, Khan I, Komers R, Kretzler M, Mercer A, Moody S, Nair V, Nawaz N, Parke K, Roberts ISD, Sayer M, Sinha S, Szklarzewicz J, Willcocks L, Barratt J

Open source

DOI: 10.1016/j.ekir.2026.107105
Published: 2026 Dec
Container: Kidney international reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.107105,
  title = {Sparsentan as First-Line Treatment in IgAN From SPARTAN.},
  author = {Cheung CK and Barratt WA and Chaki S and Chinnakotla S and Dhaun N and Graham-Brown MPM and Griffin S and Hendry B and Howson A and Jama AAA and Ju W and Khan I and Komers R and Kretzler M and Mercer A and Moody S and Nair V and Nawaz N and Parke K and Roberts ISD and Sayer M and Sinha S and Szklarzewicz J and Willcocks L and Barratt J},
  year = {2026},
  journal = {Kidney international reports},
  doi = {10.1016/j.ekir.2026.107105},
  url = {https://doi.org/10.1016/j.ekir.2026.107105}
}

RIS

TY  - JOUR
TI  - Sparsentan as First-Line Treatment in IgAN From SPARTAN.
AU  - Cheung CK
AU  - Barratt WA
AU  - Chaki S
AU  - Chinnakotla S
AU  - Dhaun N
AU  - Graham-Brown MPM
AU  - Griffin S
AU  - Hendry B
AU  - Howson A
AU  - Jama AAA
AU  - Ju W
AU  - Khan I
AU  - Komers R
AU  - Kretzler M
AU  - Mercer A
AU  - Moody S
AU  - Nair V
AU  - Nawaz N
AU  - Parke K
AU  - Roberts ISD
AU  - Sayer M
AU  - Sinha S
AU  - Szklarzewicz J
AU  - Willcocks L
AU  - Barratt J
PY  - 2026
JO  - Kidney international reports
DO  - 10.1016/j.ekir.2026.107105
UR  - https://doi.org/10.1016/j.ekir.2026.107105
ER  -

APA

CK, C., WA, B., S, C., S, C., N, D., MPM, G., S, G., B, H., A, H., AAA, J., W, J., I, K., R, K., M, K., A, M., S, M., V, N., N, N., K, P., ISD, R., M, S., S, S., J, S., L, W., & J, B. (2026). Sparsentan as First-Line Treatment in IgAN From SPARTAN.. Kidney international reports. https://doi.org/10.1016/j.ekir.2026.107105

Source records

pubmed · retrieved 2026-11-10T13:13:07.786Z